0001209191-17-031418.txt : 20170510 0001209191-17-031418.hdr.sgml : 20170510 20170510195540 ACCESSION NUMBER: 0001209191-17-031418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170510 FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1217 BUSINESS ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-697-3939 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenberg Robert J. CENTRAL INDEX KEY: 0001625594 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 17832032 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-10 0 0001625101 Pulse Biosciences, Inc. PLSE 0001625594 Greenberg Robert J. 849 MITTEN ROAD, SUITE 104 BURLINGAME CA 94010 1 0 0 0 Common Stock 2017-05-10 4 M 0 25000 2.67 A 25000 D Common Stock 2017-05-10 4 S 0 22180 21.03 D 2820 D Common Stock 2017-05-10 4 S 0 2820 21.867 D 0 D Stock Option (right to buy) 2.67 2017-05-10 4 M 0 25000 0.00 D 2020-06-01 Common Stock 25000 50655 D This is the weighted average purchase price of the shares, which ranged from $20.62 to $21.57 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $21.77 to $21.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. The shares subject to the option will vest in equal quarterly installments over a three year period that commenced on June 1, 2015 and will end on Marcn 1, 2018, subject to the Reporting Person's continued service through each vesting date. /s/ Brian Dow, as Attorney-in-Fact 2017-05-10